Nonintensive Care Unit Norepinephrine as an Alternative to Terlipressin in Hepatorenal Syndrome–Acute Kidney Injury

Vignesh Rajasekaran, Xingxing S. Cheng, Ethan Akama-Garren, Juan Garcia, Jason Phillips, Kitty Deng, Uerica Wang, Elsa Sola, Sajid Jalil, Paul Kwo, Allison J. Kwong · 2026

Read Nonintensive Care Unit Norepinephrine as an Alternative to Terlipressin in Hepatorenal Syndrome–Acute Kidney Injury by Vignesh Rajasekaran, Xingxing S. Cheng, Ethan Akama-Garren, Juan Garcia, Jason Phillips, Kitty Deng, Uerica Wang, Elsa Sola, Sajid Jalil, Paul Kwo, Allison J. Kwong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13584103.txt.

Description

Background and AimsTerlipressin is approved in the United States for the treatment of hepatorenal syndrome–acute kidney injury (HRS-AKI). At our institution, low-dose norepinephrine (NE) can be administered outside the intensive care unit (ICU) on a step-down unit for treatment of HRS-AKI.

Catalog record

CREATORVignesh Rajasekaran, Xingxing S. Cheng, Ethan Akama-Garren, Juan Garcia, Jason Phillips, Kitty Deng, Uerica Wang, Elsa Sola, Sajid Jalil, Paul Kwo, Allison J. Kwong
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13584103

Browse the full library · About the Tower of Babel